Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa: a retrospective cohort study
- PMID: 39914894
- DOI: 10.1016/S2352-3018(24)00295-9
Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa: a retrospective cohort study
Erratum in
-
Correction to Lancet HIV 2025; 12: e130-42.Lancet HIV. 2025 May 7:S2352-3018(25)00129-8. doi: 10.1016/S2352-3018(25)00129-8. Online ahead of print. Lancet HIV. 2025. PMID: 40347961 No abstract available.
Abstract
Background: Despite several service delivery models that aim to improve uptake and persistence of pre-exposure prophylaxis (PrEP) in sub-Saharan Africa, the full costs of daily oral PrEP provision in routine care settings remain largely unknown. We aimed to evaluate outcomes and costs of daily oral PrEP delivery among key and priority populations at in-facility and community outreach programmes in South Africa.
Methods: This retrospective cohort study was done at seven urban sites across South Africa with in-facility or community outreach PrEP service delivery models. We did top-down and bottom-up microcosting, from the provider perspective, of routine oral PrEP provision in programmes focusing on men who have sex with men (MSM), female sex workers, and adolescent girls and young women (aged 15-24 years) who initiated oral PrEP between March 12, 2018, and Aug 13, 2019. The primary outcome was PrEP in-hand at 6 months, defined as having sufficient PrEP drug dispensed at the last visit to have the drug available 6 months after PrEP initiation. A subset of enrolled participants with sufficient potential follow-up were included in a 12-month outcome analysis. We report the cost per client initiated on PrEP in 2021 US dollars.
Findings: We enrolled 1281 people aged at least 15 years who initiated oral PrEP in either in-facility or community outreach programmes between March 12, 2018, and Aug 13, 2019. The proportion of participants with PrEP in-hand at 6 months varied from 41·8% (95% CI 31·9-52·2; 41 of 98 participants) at one MSM-focused clinic to 0% (0-6·7; 0 of 53 participants) in an MSM-focused outreach programme. Among 633 clients receiving oral PrEP with the potential for 12 months follow-up, 86 (13·6%) had PrEP in-hand at 12 months. The mean average 6-month costs per client initiating oral PrEP ranged from US$29 (95% CI 26-31) to $590 (488-692), with higher costs generally observed for in-facility programmes ($152, 140-164) than for outreach programmes ($84, 79-88). The mean average monthly cost per client with PrEP in-hand at 6 months ranged from $18 (15-21) to $160 (126-194).
Interpretation: Costs and outcomes of daily oral PrEP provision across several populations and service delivery models in real-world settings show substantial variability. Policy makers should consider this variability when planning further scale-up of oral PrEP programmes in South Africa and the sub-Saharan Africa region to maximise opportunities to improve efficiency based on local context.
Funding: The US President's Emergency Plan for AIDS Relief, the US Agency for International Development, and the National Institutes of Health.
Copyright © 2025 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Update of
-
Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa.medRxiv [Preprint]. 2023 Aug 16:2023.08.14.23294055. doi: 10.1101/2023.08.14.23294055. medRxiv. 2023. Update in: Lancet HIV. 2025 Feb;12(2):e130-e142. doi: 10.1016/S2352-3018(24)00295-9. PMID: 37645864 Free PMC article. Updated. Preprint.
Similar articles
-
Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa.medRxiv [Preprint]. 2023 Aug 16:2023.08.14.23294055. doi: 10.1101/2023.08.14.23294055. medRxiv. 2023. Update in: Lancet HIV. 2025 Feb;12(2):e130-e142. doi: 10.1016/S2352-3018(24)00295-9. PMID: 37645864 Free PMC article. Updated. Preprint.
-
Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya.PLoS One. 2021 Apr 15;16(4):e0249625. doi: 10.1371/journal.pone.0249625. eCollection 2021. PLoS One. 2021. PMID: 33857195 Free PMC article.
-
HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.PLoS Med. 2017 Nov 21;14(11):e1002444. doi: 10.1371/journal.pmed.1002444. eCollection 2017 Nov. PLoS Med. 2017. PMID: 29161256 Free PMC article.
-
Characterizing populations prioritized for PrEP in 19 African countries: a review of national guidance.J Int AIDS Soc. 2025 Jan;28(1):e26407. doi: 10.1002/jia2.26407. J Int AIDS Soc. 2025. PMID: 39757425 Free PMC article. Review.
-
Service delivery models that promote linkages to PrEP for adolescent girls and young women and men in sub-Saharan Africa: a scoping review.BMJ Open. 2023 Mar 27;13(3):e061503. doi: 10.1136/bmjopen-2022-061503. BMJ Open. 2023. PMID: 36972966 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous